Rynel Clifton Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.30 M
- Revenue Growth 16.07%
- Profit Growth 15.71%
- Ebitda 261.13%
- Net Worth 25.86%
- Total Assets 12.42%
About Rynel Clifton Pharma
Rynel Clifton Pharma Private Limited (RCPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 June 2013 and has a history of 11 years and seven months. Its registered office is in Hisar, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.30 M.
Ashwini Kumar and Rajiv Chawla serve as directors at the Company.
Company Details
-
Location
Hisar, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33110HR2013PTC049548
-
Company No.
049548
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Jun 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Rynel Clifton Pharma Private Limited offer?
Rynel Clifton Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Eye Drops, Pharma & Bioanalytical Services, PCD Pharma Franchise.
Who are the key members and board of directors at Rynel Clifton Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwini Kumar
|
Director | 14-Jun-2013 | Current |
|
Rajiv Chawla
|
Director | 14-Jun-2013 | Current |
Financial Performance of Rynel Clifton Pharma.
Rynel Clifton Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.07% increase. The company also saw a substantial improvement in profitability, with a 15.71% increase in profit. The company's net worth Soared by an impressive increase of 25.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rynel Clifton Pharma?
In 2021, Rynel Clifton Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Grevis Pharmaceuticals Private LimitedAshwini Kumar is a mutual person
-
Eyeris Vision Care Private LimitedRajiv Chawla is a mutual person
Charges (Loans)
₹2.30 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2014 | State Bank Of India | ₹2.30 M | Open |
How Many Employees Work at Rynel Clifton Pharma?
Unlock and access historical data on people associated with Rynel Clifton Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rynel Clifton Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rynel Clifton Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.